Under his leadership, Chidamide became China’s first original small-molecule anti-tumor innovative drug and the country’s first pharmaceutical product globally licensed out
The opening of our 1000th pharmacy in Karnataka marks an important step
AEF0217 is a first-in-class CB1 receptor signaling-specific inhibitor
The deal aims to address long-standing imbalances in pharmaceutical trade while boosting investment and innovation on both sides of the Atlantic
The patent will lock in broad protection for the company’s lead therapy CardiolRx and its novel subcutaneous candidate CRD-38
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Adcock Ingram has been a cornerstone of healthcare in South Africa, known for its trusted medication brands such as Panado, Myprodol, Epi-Max, Citro-soda and Allergex
Expanding US operations to address the increased demand for API development and manufacturing
The new Houston site, Lilly's eighth U.S. manufacturing facility announced since 2020, will focus on domestic production of small molecule synthetic medicines
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Subscribe To Our Newsletter & Stay Updated
